Back to Agenda
Closing Session: Panel Discussion
Session Chair(s)
Arthur A. Levin, PhD
Distinguished Scientist, Avidity Biosciences, United States
Closing Session: Panel Discussion
Speaker(s)
Panelist
Paul C. Brown, PhD
Associate Director for Pharmacology and Toxicology, OND, CDER, FDA, United States
Panelist
Scott Henry, DrPH
Senior Vice President, Nonclinical Development, Ionis Pharmaceuticals, Inc., United States
Panelist
René Thürmer
Deputy Head of the Unit Pharmaceutical Biotechnology BfArM, Federal Institute for Drugs and Medical Devices, Germany
Panelist
G. Susan Srivatsa, PhD
President, ElixinPharma, United States
Panelist
Hobart Rogers, PharmD, PhD
Pharmacologist, CDER, FDA, United States
Panelist
Saraswathy V. Nochur, PhD, MSc
Chief Regulatory Officer, Alnylam Pharmaceuticals, United States
Have an account?